Amidrazones as precursors of biologically active compounds - Synthesis of diaminopyrazoles for evaluation of anticancer activity

Archiv der Pharmazie

Volumn 339, Issue 1, 2006, Pages 7-13

  Cocco, Maria Teresa ^a   Congiu, Cenzo ^a   Lilliu, Valentina ^a   Onnis, Valentina ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Amidrazones; Anticancer activity; Pyrazolecarboxamides

Indexed keywords

AMINE; ANTINEOPLASTIC AGENT; HYDRAZINE DERIVATIVE; ISOCYANIC ACID DERIVATIVE; NITRILE; PYRAZOLE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CROSS COUPLING REACTION; CYCLIZATION; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DIAMINES; HUMANS; HYDRAZONES; ISOCYANATES; PYRAZOLES;

EID: 31944443635     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200500179     Document Type: Article

References (22)

1. T. D. Penning, J. J. Talley, S. R. Bertenshaw, J. S. Carter, P. W. Collins, S. Docter, M. J. Graneto, L. F. Lee, J. W. Malecha, J. M. Miyashiro, R. S. Rogers, D. J. Rogier, S. S. Yu, G. D. Anderson, E. G. Burton, J. N. Cogburn, S. A. Gregory, C. M. Koboldt, W. E. Perkins, K. Seibert, A. W. Veenhuizen, Y. Y. Zhang, P. C. Isakson, J. Med. Chem. 1997, 40, 1347-1365.
2. E. Aiello, S. Aiello, F. Mingoia, A. Bacchi, G. Pelizzi, C. Musiu, M. G. Setzu, A. Pani, P. La Colla, M. E. Marongiu, Bioorg. Med. Chem. 2000, 8, 2719-2728.
3. M. S. A. El-Gaby, A. A. Atalla, A. M. Gaber, K. A. Abd Al-Wahab, Farmaco 2000, 55, 596-602.
4. B. K. Kocyigit Kaymakcioglu, S. Rollas, Farmaco 2002, 57, 595-599.
5. R. Storer, C. J. Ashton, A. D. Baxter, M. M. Kann, C. L. P. Marr, A. M. Mason, C.-L. Mo, P. L. Myers, S. A. Noble, H. R. Penn, N. G. Wier, G. Niall, J. M. Woods, P. L. Coe, Nucleosides Nucleotides 1999, 8, 203-216.
6. M. J. Genin, C. Biles, B. J. Reiser, S. M. Poppe, S. M. Swaney, W. G. Tarpley, Y. Yagi, D. L. Romero, J. Med. Chem. 2000, 43, 1034-1040.
7. O. Moukha-Chafiq, M. L. Taha, H. B. Lazrek, J.-J. Vasseur, C. Pannecouque, M. Wityrouw, E. De Clercq, Farmaco 2002, 57, 27-32.
8. J. Ishida, H. Ohtsu, Y. Tachibana, Y. Nakanishi, K. F. Bastow, M. Nagai, H.-K. Wang, H. Itokawa, K.-H. Lee, Bioorg. Med. Chem. 2002, 10, 3481-3487.
9. P. G. Baraldi, M. G. Pavani, M. D. C. Nunez, P. Brigidi, B. Vitali, R. Gambaric, R. Romagnoli, Bioorg. Med. Chem. 2002, 10, 449-456.
10. S. A. Gamage, J. A. Spicer, G. W. Rewcastle, J. Milton, S. Sohal, W. Dangerfield, P. Mistry, N. Vicker, P. A. Charlton, W. A. Denny, J. Med. Chem. 2002, 45, 740-743.
11. I. Tsutomu, K. Toshiaki, S. Hitoshi, T. Yoshinori, I. Katsutoshi, JP 01 106 866. 1989 [Chem. Abstr. 1989, 111, 194759h].
12. I. Tsutomu, Y. Hideo, K. Toshiaki, S. Hitoshi, T. Yoshinori, I. Katsutoshi, JP 01 113 371. 1989 [Chem. Abstr. 1989, 111, 214479X].
13. A. X. Wang, Q. Xie, B. Lane, K. W. Mollison, G. C. Hsieh, K. Marsh, M. P. Sheets, J. R. Luly, M. J. Coghlan, Bioorg. Med. Chem. Lett. 1998, 8, 2787-2792.
14. M. T. Cocco, C. Congiu, V. Onnis, Bioorg. Med. Chem. 2003, 11, 495-503.
15. M. T. Cocco, C. Congiu, V. Onnis, Eur. J. Med. Chem. 2003, 38, 37-47.
16. M. T. Cocco, C. Congiu, V. Lilliu, V. Onnis, Bioorg. Med. Chem. Lett. 2004, 14, 5787-5791.
17. H. G. Bonacorso, E. S. Lang, H. Lewandowski, M. A. P. Martins, C. Peppe, N. Zanatta, Inorg. Chem. Commun. 2003, 6, 646-649.
18. H. G. Bonacorso, H. Lewandowski, R. L. Drekener, M. B. Costa, C. M. P. Pereira, A. D. Wastowski, C. Peppe, M. A. P. Martins, N. Zanatta, J. Fluorine Chem. 2003, 122, 159-163.
19. A. M. Bernard, M. T. Cocco, C. Congiu, V. Onnis, P. P. Piras, J. Heterocyclic Chem. 1999, 36, 1183-1188.
20. G. D. Gray, E. Wickstrom, Biotechniques 1996, 21, 780-782.
21. M. T. Cocco, C. Congiu, A. Maccioni, J. Heterocyclic Chem. 1990, 27, 683-686.
22. A. M. Bernard, M. T. Cocco, C. Congiu, V. Onnis, P. P. Piras, J. Heterocyclic Chem. 1996, 33, 1771-1773.